Esoper RD Tablet is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed to manage gastrointestinal disorders characterized by acid reflux, heartburn, and delayed gastric emptying. Domperidone, a dopamine D2 receptor antagonist, facilitates gastric motility by enhancing the movement of stomach contents into the intestines, thereby alleviating symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, effectively suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing symptomatic relief from acid-related disorders including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcers. The synergistic action of these two agents helps in reducing both the causative acid secretion and improving gastric emptying, offering comprehensive management of upper gastrointestinal symptoms. Esoper RD Tablet is typically prescribed for patients who require both acid suppression and prokinetic therapy. It should be used under medical supervision with appropriate dosage adjustments based on clinical response and patient tolerance. Caution is advised in patients with known hypersensitivity to either component, and it is contraindicated in those with prolactinoma or gastrointestinal obstruction. Regular monitoring is recommended to assess therapeutic efficacy and detect potential adverse effects.